{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T12:49:22Z","timestamp":1785761362895,"version":"3.56.0"},"reference-count":20,"publisher":"BMJ","issue":"8","license":[{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"unspecified","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2026,6,27]]},"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Bladder cancer (BC), the second most common urinary cancer, is classified as either non-muscle-invasive BC or muscle-invasive BC. Although numerous studies have identified potential prognostic biomarkers, none have yet been implemented in clinical practice. A comprehensive umbrella review comparing all prognostic biomarkers in BC remains absent. Thus, we aim to synthesise evidence from systematic reviews and meta-analyses on prognostic factors in patients with BC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>\n                      We will search PubMed\/MEDLINE, Scopus, Web of Science (WOS), EMBASE, Cochrane Database of Systematic Reviews (CDSR), Google Scholar and EPISTEMONIKOS for systematic reviews of BC prognostic biomarkers from the inception date to 1 November 2025. Title and abstract will be screened for potentially relevant studies. Then two reviewers will independently select eligible reviews based on eligibility criteria. A data extraction sheet will be used to extract relevant information. The risk of bias in the included reviews will be assessed with the Risk of Bias in systematic reviews tool. Using the random-effects model for each prognostic biomarker, we will estimate the pooled HR and its 95% CI as well as the prediction interval and its 95% CI. To quantify heterogeneity between studies, we will use the I\n                      <jats:sup>2<\/jats:sup>\n                      metric. We will use contour funnel plots, doi plots, the Egger test and the Copas method to evaluate evidence of small-study effects. The credibility assessment will be assessed using the following items: level of statistical significance, number of cases, degree of statistical heterogeneity, significance of the PI, evidence of small-study effects and excess significance bias. We will perform sensitivity analyses with multiple approaches.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>Formal ethical approval is not required, as primary data will not be collected in this study. The findings of this study will be disseminated through peer-reviewed publications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PROSPERO registration number<\/jats:title>\n                    <jats:p>CRD42024602432.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2026-118810","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T12:05:20Z","timestamp":1785758720000},"page":"e118810","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic value of different biomarkers in bladder cancer: protocol for an umbrella review of systematic reviews and meta-analyses"],"prefix":"10.1136","volume":"16","author":[{"given":"Seyed Mohammad Kazem","family":"Aghamir","sequence":"first","affiliation":[{"name":"Urology Research Center, Tehran University of Medical Sciences, Tehran, Tehran, Iran (the Islamic Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramin","family":"Rahimnia","sequence":"additional","affiliation":[{"name":"Department of Medical Nanotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran (the Islamic Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Taheri","sequence":"additional","affiliation":[{"name":"Kidney Disease Research Center, Department of Pathology, Isfahan University of Medical Sciences, Isfahan, Iran (the Islamic Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Ebrahimi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Faculty of Medicine, Tehran University of Medical Sciences, Sina Hospital, Tehran, Iran (the Islamic Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Taghi","family":"Talebian","sequence":"additional","affiliation":[{"name":"Tehran University of Medical Sciences, Sina Hospital, Tehran, Iran (the Islamic Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbasali","family":"Keshtkar","sequence":"additional","affiliation":[{"name":"Urology Research Center, Tehran University of Medical Sciences, Tehran, Tehran, Iran (the Islamic Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0250-5714","authenticated-orcid":false,"given":"Mohammadreza","family":"Ghasemi","sequence":"additional","affiliation":[{"name":"Urology Research Center, Tehran University of Medical Sciences, Tehran, Tehran, Iran (the Islamic Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Danial","family":"Mohammadi","sequence":"additional","affiliation":[{"name":"Department of Anatomy, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran (the Islamic Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iman","family":"Menbari Oskouie","sequence":"additional","affiliation":[{"name":"Urology Research Center, Tehran University of Medical Sciences, Tehran, Tehran, Iran (the Islamic Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parsa","family":"Nikoofar","sequence":"additional","affiliation":[{"name":"Department of Urology, Thunder Bay Regional Research Institute, Thunder Bay, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Khatami","sequence":"additional","affiliation":[{"name":"Urology Research Center, Tehran University of Medical Sciences, Tehran, Tehran, Iran (the Islamic Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,8,3]]},"reference":[{"key":"2026080305050973000_16.8.e118810.1","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2018.07.013","article-title":"SnapShot: Bladder Cancer","volume":"34","author":"Hurst","year":"2018","journal-title":"Cancer Cell"},{"key":"2026080305050973000_16.8.e118810.2","doi-asserted-by":"crossref","first-page":"103951","DOI":"10.1016\/j.jprot.2020.103951","article-title":"Comparative bioinformatics analysis of prognostic and differentially expressed genes in non-muscle and muscle invasive bladder cancer","volume":"229","author":"Silva","year":"2020","journal-title":"J Proteomics"},{"key":"2026080305050973000_16.8.e118810.3","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15072149","article-title":"Risk Classification of Bladder Cancer by Gene Expression and Molecular Subtype","volume":"15","author":"Blanca","year":"2023","journal-title":"Cancers (Basel)"},{"key":"2026080305050973000_16.8.e118810.4","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1170124","article-title":"Intermediate and high-risk non-muscle-invasive bladder cancer: an overview of epidemiology, burden, and unmet needs","volume":"13","author":"Grabe-Heyne","year":"2023","journal-title":"Front Oncol"},{"key":"2026080305050973000_16.8.e118810.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2021.08.010"},{"key":"2026080305050973000_16.8.e118810.6","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.eururo.2014.07.033","article-title":"Inflammatory Biomarkers and Bladder Cancer Prognosis: A Systematic Review","volume":"66","author":"Masson-Lecomte","year":"2014","journal-title":"Eur Urol"},{"key":"2026080305050973000_16.8.e118810.7","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.clgc.2024.01.008","article-title":"The Prognostic Value of Tumor Infiltrating Lymphocytes After Radical Cystectomy for Bladder Cancer: A Systematic Review and Meta-Analysis","volume":"22","author":"Kawada","year":"2024","journal-title":"Clin Genitourin Cancer"},{"key":"2026080305050973000_16.8.e118810.8","doi-asserted-by":"crossref","first-page":"25294","DOI":"10.18632\/oncotarget.25334","article-title":"Prognostic roles of tumor associated macrophages in bladder cancer: a system review and meta-analysis","volume":"9","author":"Wu","year":"2018","journal-title":"Oncotarget"},{"key":"2026080305050973000_16.8.e118810.9","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.731318","article-title":"Predictive Value of Preoperative Positive Urine Cytology for Development of Bladder Cancer After Nephroureterectomy in Patients With Upper Urinary Tract Urothelial Carcinoma: A Prognostic Nomogram Based on a Retrospective Multicenter Cohort Study and Systematic Meta-Analysis","volume":"11","author":"Fan","year":"2021","journal-title":"Front Oncol"},{"key":"2026080305050973000_16.8.e118810.10","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-17-2719"},{"key":"2026080305050973000_16.8.e118810.11","doi-asserted-by":"crossref","unstructured":"Natesan D , Zhang L , Martell HJ , et al . n.d. APOBEC Mutational Signature and Tumor Mutational Burden as Predictors of Clinical Outcomes and Treatment Response in Patients With Advanced Urothelial Cancer. Front Oncol 12. doi:10.3389\/fonc.2022.816706","DOI":"10.3389\/fonc.2022.816706"},{"key":"2026080305050973000_16.8.e118810.12","doi-asserted-by":"crossref","unstructured":"Mei Y , Zheng J , Xiang P , et al . n.d. Prognostic value of the miR-200 family in bladder cancer. Medicine (Baltimore) 99:e22891. doi:10.1097\/MD.0000000000022891","DOI":"10.1097\/MD.0000000000022891"},{"key":"2026080305050973000_16.8.e118810.13","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1080\/0284186X.2021.1886323","article-title":"Prognostic role of neutrophil-to-lymphocyte ratio (NLR) in urological tumors: an umbrella review of evidence from systematic reviews and meta-analyses","volume":"60","author":"Mjaess","year":"2021","journal-title":"Acta Oncol (Madr)"},{"key":"2026080305050973000_16.8.e118810.14","doi-asserted-by":"crossref","unstructured":"Moher D , Shamseer L , Clarke M , et al . Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev 2015;4. doi:10.1186\/2046-4053-4-1","DOI":"10.1186\/2046-4053-4-1"},{"key":"2026080305050973000_16.8.e118810.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2015.06.005"},{"key":"2026080305050973000_16.8.e118810.16","doi-asserted-by":"crossref","unstructured":"Olivier J , May WL , Bell ML . Relative effect sizes for measures of risk. Commun Stat - Theory Methods. Commun Stat - Theory Methods 2017;6774\u201381. doi:10.1080\/03610926.2015.1134575","DOI":"10.1080\/03610926.2015.1134575"},{"key":"2026080305050973000_16.8.e118810.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2013.11.007"},{"key":"2026080305050973000_16.8.e118810.18","first-page":"1","article-title":"Prognostic Significance of the Lymphocyte-to-Monocyte Ratio in Bladder Cancer Undergoing Radical Cystectomy: A Meta-Analysis of 5638 Individuals","volume":"2019","author":"Ma","year":"2019","journal-title":"Dis Markers"},{"key":"2026080305050973000_16.8.e118810.19","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1080\/21655979.2021.1915725","article-title":"The role of telomerase reverse transcriptase (TERT) promoter mutations in prognosis in bladder cancer","volume":"12","author":"Wan","year":"2021","journal-title":"Bioengineered"},{"key":"2026080305050973000_16.8.e118810.20","doi-asserted-by":"crossref","unstructured":"Chen Y , Shi K , Fu X , et al . n.d. Diagnostic and prognostic potential of exosome non-coding RNAs in bladder cancer: a systematic review and meta-analysis. Front Oncol 14. doi:10.3389\/fonc.2024.1336375","DOI":"10.3389\/fonc.2024.1336375"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2026-118810","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T12:05:23Z","timestamp":1785758723000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2026-118810"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":20,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8,3]]},"published-print":{"date-parts":[[2026,8]]}},"alternative-id":["10.1136\/bmjopen-2026-118810"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2026-118810","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8]]}}}